Tilray Stock Surges Post Q1 Earnings Report, Here’s Why

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) reported on Thursday a revenue beat in the first quarter of fiscal 2026. The company’s stock saw a strong rebound following the earnings results release. It surged 23.5% trading at $2.12 per share at the time of writing on Thursday, reflecting renewed investor optimism.

The company reported a record net revenue of $210 million for the quarter, representing a 5% year-over-year increase, driven by growth in both its cannabis and distribution segments.

Net income totaled $1.5 million for the period, marking a return to profitability after a $34.7 million loss in the same quarter last year.

Adjusted EBITDA improved 9.7% year-over-year to $10.2 million, highlighting stronger operating efficiency. Tilray also strengthened its balance sheet, reporting a cash position of $265 million and reducing net debt to $4 million.

Irwin D. Simon, chairman and CEO, said the quarter underscored Tilray’s progress toward sustainable profitability and global diversification. Tilray has operations in Canada, the U.S., Europe, and Latin America.

“Our global platform, proven expertise in medical and adult-use cannabis, and trusted partnerships with patients, healthcare professionals, and policymakers set us apart as the partner of choice in this dynamic industry,” Simon said.

Looking ahead to 2026, Tilray eyes opportunities in emerging markets within the Middle East, India, Türkiye and Asia with a focus on non-alcoholic beer, beverages and hemp-based food product sales.

“Looking forward, I am confident in Tilray’s ability to seize the transformative opportunities ahead, especially as the U.S. explores cannabis rescheduling and the European cannabis landscape continues to evolve,” Simon added.